Krystal Biotech, Inc. KRYS Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingActivitiesCashFlowStatement.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s other working capital?
- Krystal Biotech, Inc. (KRYS) reported other working capital of $136K in Q1 2026.
- How has Krystal Biotech, Inc.'s other working capital changed year-over-year?
- Krystal Biotech, Inc.'s other working capital decreased by 77.9% year-over-year, from $614K to $136K.
- What is the long-term trend for Krystal Biotech, Inc.'s other working capital?
- Over 2 years (2021 to 2023), Krystal Biotech, Inc.'s other working capital has grown at a -30.9% compound annual growth rate (CAGR), from -$454K to $217K.
- What does other working capital mean?
- The net cash impact of changes in miscellaneous short-term assets and liabilities.
- How do you interpret other working capital?
- Large fluctuations may indicate volatility in operational processes or accounting accruals.
- How does other working capital compare across companies?
- Standard line item in cash flow statements to ensure all balance sheet movements are accounted for.